The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence

Fan Zhang1,2,3, Yuan Wang1,2, Luyang Zhang1,2

  • 1Xuanwu Hospital Capital Medical University, Beijing, China.

Elife
|July 7, 2025
PubMed

Insights

CHMP5 protein dysfunction disrupts the endolysosomal pathway, leading to skeletal cell senescence and bone abnormalities. Eliminating senescent cells offers a potential therapy for these musculoskeletal disorders.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Skeletal Biology

Background:

  • Endolysosomal pathway dysfunction, observed in lysosomal storage diseases, is linked to musculoskeletal disorders.
  • The precise mechanisms connecting endolysosomal dysfunction to skeletal abnormalities are not well understood, hindering therapeutic development.

Purpose of the Study:

  • To investigate the role of CHMP5 in maintaining the endolysosomal pathway and regulating bone formation.
  • To elucidate the molecular mechanisms by which endolysosomal dysfunction leads to musculoskeletal abnormalities.

Main Methods:

  • Genetic ablation of CHMP5 in mouse osteogenic cells.
  • In vivo and in vitro bone formation assays.
  • Analysis of endolysosomal and mitochondrial function, reactive oxygen species (ROS) levels, and cell senescence.
  • Evaluation of senolytic drug efficacy in CHMP5 knockout mice.

Main Results:

  • Genetic deletion of CHMP5 in osteogenic cells enhanced bone formation.
  • CHMP5 deficiency led to endolysosomal dysfunction, decreased VPS4A protein, impaired mitochondrial function, and increased mitochondrial ROS.
  • These cellular changes resulted in skeletal cell senescence, causing abnormal bone formation.
  • Elimination of senescent cells using senolytic drugs ameliorated musculoskeletal abnormalities in CHMP5 knockout mice.

Conclusions:

  • CHMP5 is crucial for endolysosomal pathway integrity and normal bone development.
  • Endolysosomal dysfunction, mediated by CHMP5 loss, drives skeletal cell senescence via mitochondrial impairment.
  • Cellular senescence is a key mechanism underlying musculoskeletal disorders associated with endolysosomal pathway defects and presents a therapeutic target.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
24.0K